8-aminoquinoline has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meunier, B; Nguyen, M; Robert, A; Sournia-Saquet, A; Vendier, L | 1 |
| Ceccom, J; Coslédan, F; Francès, B; Halley, H; Lassalle, JM; Meunier, B | 1 |
2 other study(ies) available for 8-aminoquinoline and Alzheimer Disease
| Article | Year |
|---|---|
Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Aminoquinolines; Amyloid beta-Peptides; Chelating Agents; Coordination Complexes; Copper; Crystallography, X-Ray; Drug Stability; Electrochemical Techniques; Electrodes; Humans; Hydrogen Peroxide; Kinetics; Molecular Conformation; Oxidation-Reduction; Protein Binding; Serum Albumin | 2014 |
Copper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse model.
Topics: Alzheimer Disease; Aminoquinolines; Amyloid beta-Peptides; Animals; Chelating Agents; Cognition; Copper; Disease Models, Animal; Injections; Male; Memory, Episodic; Mice; Mice, Inbred C57BL; Peptide Fragments; Recovery of Function; Time Factors | 2012 |